Global Blood Therapeutics, Inc. (GBT), is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. More »

Featured News

Recent News

09/05/19GBT Announces U.S. Food and Drug Administration Acceptance of New Drug Application and Priority Review for Voxelotor for the Treatment of Sickle Cell Disease
09/04/19GBT Announces New Employment Inducement Grants
09/03/19GBT Announces Participation at the 2019 Morgan Stanley Global Healthcare Conference
09/03/19GBT and Sickle Cell Disease Association of America to Host 8th Annual Sickle Cell Disease (SCD) Therapeutics Conference

More »

Media Resources

Media Contact

Stephanie Yao